Company Description
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific.
The company offers Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.
It also provides Accounting/General Ledger System, a proper double-entry ledger that automates the posting of general ledger journal entries for all cash and securities transactions for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services.
Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.
| Country | United States |
| Founded | 1998 |
| IPO Date | Oct 21, 2021 |
| Industry | Software - Application |
| Sector | Technology |
| Employees | 1,143 |
| CEO | Oleg Movchan |
Contact Details
Address: 125 South Clark Street, Suite 750 Chicago, Illinois 60603 United States | |
| Phone | 312 253 9800 |
| Website | enfusion.com |
Stock Details
| Ticker Symbol | ENFN |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $17.00 |
| CIK Code | 0001868912 |
| CUSIP Number | 292812104 |
| ISIN Number | US2928121043 |
| SIC Code | 7372 |
Key Executives
| Name | Position |
|---|---|
| Oleg Movchan | Chief Executive Officer and Director |
| Bradley Herring | Chief Financial Officer |
| Neal Pawar | Chief Operating Officer |
| Stephen Malherbe | Managing Partner |
| Valeria Gutowski | Chief Accounting Officer |
| Daniel Groman | Chief Technology Officer |
| Matthew R. Campobasso | General Counsel and Corporate Secretary |
| Bronwen Bastone | Chief People Officer |
| Joseph Defeo | Global Head of Managed Services Production |
| Jeff Young | Head of Implementation |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 21, 2025 | SCHEDULE 13G/A | Filing |
| Apr 21, 2025 | SCHEDULE 13G/A | Filing |
| Apr 21, 2025 | SCHEDULE 13G/A | Filing |
| Apr 21, 2025 | SCHEDULE 13G/A | Filing |
| Apr 21, 2025 | POS AM | Post-Effective amendments for registration statement |
| Apr 21, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Apr 21, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Apr 21, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Apr 21, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Apr 21, 2025 | 8-K | Current Report |